Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy
Frédérique Chammartin(University of Basel), Heiner C. Bucher(University of Basel), Lene Ryom(University of Copenhagen), Andrew Phillips(Wake Forest University), Wafaa El‐Sadr(Columbia University Irving Medical Center), Camilla Ingrid Hatleberg(University of Copenhagen), Ole Kirk(University of Copenhagen), Sara Lodi(Boston University), Fabrice Bonnet(Centre Hospitalier Universitaire de Bordeaux), Christian Pradier(Université Côte d'Azur), Amanda Mocroft(University of Copenhagen), Antonella d’Arminio Monforte(University of Milan), Matthew Law(UNSW Sydney), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Roger Logan(Harvard University), Caroline Sabin(Primary Health Care), Peter Reiss(Amsterdam Institute for Global Health and Development)
Cited by 25
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k